Introduction The pathogenic and highly transmissible etiological agent, SARS-CoV-2, has
caused a serious threat COVID-19 pandemic. WHO has declared the epidemic a public …

The SARS-CoV-2 outbreak that emerged at the end of 2019 has affected more than 58
million people with more than 1.38 million deaths and has had an incalculable impact on the …

Emerging epidemic-prone diseases have introduced numerous health and economic
challenges in recent years. Given current knowledge of COVID-19, herd immunity through …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged,
causing a global pandemic called COVID-19. Currently, there is no definitive treatment for …

At the beginning of COVID-19, we underlined that this pandemic was a new challenge for
rheumatologists. On the one hand, it was necessary to clarify the impact of this new viral …

Cytokines, chemokines and growth factors present different expression profiles related to the
prognosis of COVID-19. We analyzed clinical parameters and assessed the expression of …

COVID-19 is a respiratory disease caused by newly discovered severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The disease at first was identified in the city of …

This study aims to assess anakinra's safety and efficacy for treating severe coronavirus
disease 2019 (COVID-19). Numerous electronic databases were searched and finally 15 …

The aim of this study was to evaluate differences in the clinical manifestations and outcomes
in hospitalized patients with COVID-19 in a single Romanian center during four pandemic …

Abstract Objective Coronavirus disease 2019 (COVID-19) is a world-wide pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, treatment of …